MASLD in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
Show: UAB Med Cast
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a new, more precise name for nonalcoholic fatty liver disease. Fernando Bril, M.D., an endocrinologist, explains how this name precisely describes the way in which fatty acids build up in the liver of patients who have insulin resistance. Learn more about the close relationship of MASLD, type 2 diabetes, and obesity. Dr. Bril reviews current screening recommendations, effective interventions, and the first approved drug for the condition.
More From Current Show
For patients with cancer, “immunocompromised” is not a complete assessment of infection risk. Jeremey Walker, M.D., and Emily...
Listen Now Is this mole something to worry about? Surgical oncologist, Taranjit Arora, M.D., explains how clinicians use the ABCDEs...
Listen Now As demand for donor hearts continues to outpace supply, donation after circulatory death (DCD) is helping expand access...
Listen Now Sepsis remains a leading cause of hospital mortality in preterm infants, but treating suspected cases as medical emergencies...
Listen Now Although essential for some patients, central lines create an ongoing risk of infection. Senior Director of Infection Prevention...
Listen Now OR delays may never be eliminated, but many can be prevented. Napoleon Player, DNP, associate vice president of...
Listen Now Early recognition of progressive pulmonary fibrosis (PPF) is critical because further lung damage cannot be reversed. Teja Kulkarni,...
Listen Now Maximizing surgical safety takes more than a static checklist. UAB surgeons Melanie Morris, M.D., Helen Krontiras, M.D., and...
Listen Now Related Episodes
Explore the complex emotional landscape that accompanies diabetes in young patients. Dr. Mercedes Palacios discusses common emotional responses,...
Listen Now 
